The U.S. Senate today agreed, 51-50, to begin debate on the House-passed bill, H.R. 1628, “The American Health Care Act of 2017.” The vote was 50 Republican Senators in favor of the motion to proceed. Two Republican Senators and 48 Democratic Senators voted against. Vice President Pence voted in favor of the motion to break the tie.
The House passed H.R. 1628 on May 4, 2017. H.R. 1628 includes tax provisions. Read TaxNewsFlash-Legislative Update
The procedural vote today is the first action by the Senate in what could be a lengthy legislative process. H.R. 1628 is being considered by the Senate under a special budgetary process known as "reconciliation." The reconciliation process includes a number of special rules, including allowing legislation to be approved by the Senate with a simple majority vote (thus potentially allowing Senate approval with only Republican support), limiting debate on the bill to a maximum of 20 hours, and allowing unlimited amendments.
It is expected that a great number of amendments will be offered, possibly including several alternative bills, prior to a final vote. Thus, it is possible that any bill that may ultimately pass the Senate would be different from H.R. 1628 as approved by the House.
The House and Senate must ultimately pass identical versions of a bill before it can be signed by the president and become law.
© 2017 KPMG LLP, a Delaware limited liability partnership and the U.S. member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved.
The KPMG logo and name are trademarks of KPMG International. KPMG International is a Swiss cooperative that serves as a coordinating entity for a network of independent member firms. KPMG International provides no audit or other client services. Such services are provided solely by member firms in their respective geographic areas. KPMG International and its member firms are legally distinct and separate entities. They are not and nothing contained herein shall be construed to place these entities in the relationship of parents, subsidiaries, agents, partners, or joint venturers. No member firm has any authority (actual, apparent, implied or otherwise) to obligate or bind KPMG International or any member firm in any manner whatsoever. The information contained in herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.